About Us
Dr. Jamie Lucien - Director
Dr. Jamie Lucien - Director
Dr. Jamie Lucien - Director
Dr. Lucien is a lawyer and patent agent with over 20 years of experience as legal counsel and patent counsel for innovative Pharma and Biotech public companies. As patent counsel, he prosecuted the patent portfolio for Aurinia Pharmaceutical’s flagship registered product Lupkynis (voclosporin). The focus of his practice has been strategic
Dr. Lucien is a lawyer and patent agent with over 20 years of experience as legal counsel and patent counsel for innovative Pharma and Biotech public companies. As patent counsel, he prosecuted the patent portfolio for Aurinia Pharmaceutical’s flagship registered product Lupkynis (voclosporin). The focus of his practice has been strategic intellectual property portfolio development, product development, and preparing companies for financing and licensing transactions. In addition to his legal credentials, Jamie holds an M.Sc. in Experimental Pathology, and a Ph.D. in Medical Sciences (Immunology).
John Porter - Director
Dr. Jamie Lucien - Director
Dr. Jamie Lucien - Director
John has over 35 years of experience in the Life Sciences sector covering Pharma/Biotech, Lab Diagnostics and Medical Devices. He possesses a successful track record of innovative technology commercialization including market assessment, reimbursement, KOL development, product launch and distribution strategies on a global basis. John als
John has over 35 years of experience in the Life Sciences sector covering Pharma/Biotech, Lab Diagnostics and Medical Devices. He possesses a successful track record of innovative technology commercialization including market assessment, reimbursement, KOL development, product launch and distribution strategies on a global basis. John also has successfully managed full P/L responsibility in lab diagnostics and has executed licensing agreements in the pharma/biotech space.
Prior to co-founding Vesmyr Life Sciences, John was Senior Director of Business Development at Isotechnika Pharma (Aurinia) where his responsibilities included all related BD activities globally in support of licensing lead compounds in development for transplant and autoimmune indications which included identifying and securing strategic license partnerships negotiations, due diligence, market analysis, term sheets and valuations.
Advisory Team
Mark D. Abel, Ph.D.
Dr. Abel has over 35 years of experience in the pharmaceutical industry, having held positions of increasing responsibility progressing from Research Chemist to Senior Director, Chemistry and Manufacturing. He has direct hands-on expertise in drug discovery, lead optimization, chemical process development and scale-up, drug substance and
Dr. Abel has over 35 years of experience in the pharmaceutical industry, having held positions of increasing responsibility progressing from Research Chemist to Senior Director, Chemistry and Manufacturing. He has direct hands-on expertise in drug discovery, lead optimization, chemical process development and scale-up, drug substance and drug product manufacturing, stability studies, due diligence, preparation of regulatory submissions, and oversight of third-party contract research and contract manufacturing organizations. Dr. Abel has the unique experience of having worked directly on the development of a current commercial product every step of the way from its conception through to regulatory approval and successful commercialization.
Dr. Abel holds a BSc degree in chemistry from the University of Alberta and a PhD in pharmaceutical chemistry from Tohoku Pharmaceutical University, Sendai, Japan. He is the author or co-author of numerous scientific papers, abstracts and patents.